Every filing for 014442107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
RA Capital Management, L.P.
13G
|
5.1% |
10/26/2026
Event 10/19/2026
|
|
| RA Capital Management, L.P. | 5.1% | ||
| Peter Kolchinsky | 5.1% | ||
| Rajeev Shah | 5.1% | ||
| RA Capital Healthcare Fund, L.P. | 5.1% | ||
|
Deep Track Capital, LP
13G
|
8.6% |
10/23/2026
Event 10/16/2026
|
|
| Deep Track Capital, LP | 8.6% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 8.6% | ||
| David Kroin | 8.6% | ||
|
Biotechnology Value Fund L P
13G
|
8.4% |
9/18/2026
Event 9/11/2026
|
|
| Biotechnology Value Fund L P | 4.4% | ||
| BVF I GP LLC | 4.4% | ||
| Biotechnology Value Fund II LP | 3.3% | ||
| BVF II GP LLC | 3.3% | ||
| Biotechnology Value Trading Fund OS LP | 0.6% | ||
| BVF Partners OS Ltd. | 0.6% | ||
| BVF GP Holdings LLC | 7.7% | ||
| BVF Partners L P/IL | 8.4% | ||
| BVF Inc/IL | 8.4% | ||
| Lampert Mark N | 8.4% | ||
|
Polaris Venture Partners VI, L.P.
13G/A
Amendment 7
|
4.7% |
5/14/2026
Event 3/31/2026
|
|
| Polaris Venture Partners VI, L.P. | 0.5% | ||
| Polaris Venture Partners Founders' Fund VI, L.P. | 0.2% | ||
| Polaris Venture Partners VI (AIV), L.P. | 3.0% | ||
| Polaris Venture Partners VI (AIV-B), L.P. | 0.7% | ||
| Polaris Venture Management Co VI, L.L.C. | 4.4% | ||
| David Barrett | 4.4% | ||
| Brian Chee | 4.4% | ||
| Jonathan A. Flint | 4.4% | ||
| Terrance G. McGuire | 4.7% | ||
| Amir Nashat | 4.5% | ||
| Bryce Youngren | 4.4% | ||
| BlackRock, Inc. 13G | 5.2% |
4/27/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 5 | 0% |
3/26/2026
Event 3/13/2026
|
|
|
RTW Investments, LP
13G/A
Amendment 1
|
0% |
2/17/2026
Event 12/31/2025
|
|
| RTW Investments, LP | 0% | ||
| Roderick Wong | 0% | ||
| Arnon Rosenthal 13G/A Amendment 3 | 7.4% |
2/6/2026
Event 12/31/2025
|
|
| Vanguard Group Inc 13G/A Amendment 4 | 6.3% |
1/30/2026
Event 12/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 6 | 4.7% |
1/21/2026
Event 12/31/2025
|
|
|
RTW Investments, LP
13G
|
6.9% |
11/14/2025
Event 9/30/2025
|
|
| RTW Investments, LP | 6.9% | ||
| Roderick Wong | 6.9% | ||
|
TCG Crossover GP II, LLC
13G
|
9.2% |
11/14/2025
Event 10/22/2025
|
|
| TCG Crossover GP II, LLC | 4.6% | ||
| TCG Crossover Fund II, L.P. | 4.6% | ||
| TCG Crossover GP III, LLC | 4.6% | ||
| TCG Crossover Fund III, L.P. | 4.6% | ||
| Chen Yu | 9.2% | ||
|
Polaris Venture Partners VI, L.P.
13G/A
Amendment 6
|
6.5% |
11/13/2025
Event 9/30/2025
|
|
| Polaris Venture Partners VI, L.P. | 0.5% | ||
| Polaris Venture Partners Founders' Fund VI, L.P. | 0.3% | ||
| Polaris Venture Partners VI (AIV), L.P. | 4.4% | ||
| Polaris Venture Partners VI (AIV-B), L.P. | 1.1% | ||
| Polaris Venture Management Co VI, L.L.C. | 6.3% | ||
| David Barrett | 6.3% | ||
| Brian Chee | 6.3% | ||
| Jonathan A. Flint | 6.3% | ||
| Terrance G. McGuire | 6.5% | ||
| Amir Nashat | 6.4% | ||
| Bryce Youngren | 6.4% | ||
|
FMR LLC
13G/A
Amendment 4
|
3.6% |
11/7/2025
Event 10/31/2025
|
|
| FMR LLC | 3.6% | ||
| Abigail P. Johnson | 3.6% | ||
| BlackRock, Inc. 13G/A Amendment 5 | 5.1% |
10/17/2025
Event 9/30/2025
|
|
|
RA Capital Management, L.P.
13G/A
Amendment 1
|
0% |
8/14/2025
Event 6/30/2025
|
|
| RA Capital Management, L.P. | 0% | ||
| Peter Kolchinsky | 0% | ||
| Rajeev Shah | 0% | ||
| RA Capital Healthcare Fund, L.P. | 0% | ||
| BlackRock, Inc. 13G/A Amendment 4 | 6.2% |
4/17/2025
Event 3/31/2025
|
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 138 | 95.0 M | $176M |
| 2026 Q2 | 141 | 91.2 M | $183M |
| 2026 Q1 | 139 | 88.4 M | $190M |
| 2025 Q4 | 131 | 84.5 M | $132M |
| 2025 Q3 | 150 | 74.7 M | $221M |
| 2025 Q2 | 137 | 70.5 M | $98.7M |
| 2025 Q1 | 142 | 72.6 M | $89.8M |
| 2024 Q4 | 151 | 73.4 M | $139M |
| 2024 Q3 | 161 | 72.5 M | $338M |
| 2024 Q2 | 163 | 72.8 M | $330M |
| 2024 Q1 | 159 | 74.2 M | $447M |
| 2023 Q4 | 151 | 63.9 M | $510M |
| 2023 Q3 | 150 | 62.1 M | $403M |
| 2023 Q2 | 146 | 59.0 M | $355M |
| 2023 Q1 | 151 | 58.3 M | $361M |
| 2022 Q4 | 157 | 54.8 M | $506M |
| 2022 Q3 | 169 | 54.6 M | $516M |
| 2022 Q2 | 155 | 53.8 M | $547M |
| 2022 Q1 | 167 | 55.4 M | $790M |
| 2021 Q4 | 168 | 54.7 M | $1.13B |
| 2021 Q3 | 148 | 52.2 M | $1.19B |
| 2021 Q2 | 142 | 49.2 M | $1.02B |
| 2021 Q1 | 129 | 46.3 M | $932M |
| 2020 Q4 | 137 | 46.3 M | $700M |
| 2020 Q3 | 145 | 49.5 M | $522M |
| 2020 Q2 | 140 | 50.1 M | $1.22B |
| 2020 Q1 | 109 | 47.9 M | $1.16B |
| 2019 Q4 | 84 | 37.1 M | $639M |
| 2019 Q3 | 77 | 34.7 M | $500M |
| 2019 Q2 | 64 | 29.1 M | $551M |
| 2019 Q1 | 55 | 28.7 M | $526M |